GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bicara Therapeutics Inc (NAS:BCAX) » Definitions » PB Ratio

BCAX (Bicara Therapeutics) PB Ratio : (As of Dec. 13, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Bicara Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-13), Bicara Therapeutics's share price is $17.50. Bicara Therapeutics's Book Value per Share for the quarter that ended in Jun. 2024 was $-3.38. Hence, Bicara Therapeutics's PB Ratio of today is .

The historical rank and industry rank for Bicara Therapeutics's PB Ratio or its related term are showing as below:

BCAX's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.48
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio


Bicara Therapeutics PB Ratio Historical Data

The historical data trend for Bicara Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bicara Therapeutics PB Ratio Chart

Bicara Therapeutics Annual Data
Trend Dec22 Dec23
PB Ratio
- -

Bicara Therapeutics Semi-Annual Data
Dec22 Jun23 Dec23 Jun24
PB Ratio - - - -

Competitive Comparison of Bicara Therapeutics's PB Ratio

For the Biotechnology subindustry, Bicara Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bicara Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bicara Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Bicara Therapeutics's PB Ratio falls into.



Bicara Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Bicara Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2024)
=17.50/-3.377
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Bicara Therapeutics  (NAS:BCAX) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Bicara Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of Bicara Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bicara Therapeutics Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
116 Huntington Avenue, Suite 703, Boston, MA, USA, 02116
Website
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.